Top 4 NYSE Stocks In The Drug Delivery Industry With The Highest Revenue

Below are the top drug delivery stocks on the NYSE in terms of revenue. The trailing-twelve-month revenue at Hospira HSP is $4.02 billion. Hospira had $655.90 million in total cash for the latest quarter. The trailing-twelve-month revenue at Valeant Pharmaceuticals International VRX is $2.75 billion. Valeant Pharmaceuticals' operating margin for the same period is 23.99%. The trailing-twelve-month revenue at Elan Corporation plc ELN is $1.29 billion. Elan's ROE for the same period is 102.84%. The trailing-twelve-month revenue at K-V Pharmaceutical Company KV is $23.20 million. K-V Pharmaceutical had $50.70 million in total cash for the latest quarter.